Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 ILa | +7.14% | +7.14% | +15.38% |
Jun. 05 | Can-Fite Biopharma Ltd. Updates on Its Advanced Liver Cancer Pivotal Phase 3 Study | CI |
May. 12 | Transcript : Can-Fite BioPharma Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.38% | 11.37M | |
-0.28% | 90.59B | |
0.00% | 38.99B | |
-8.52% | 34.09B | |
+64.13% | 26.38B | |
-17.37% | 15.02B | |
-5.99% | 13.17B | |
-10.69% | 11.88B | |
-47.78% | 10.65B | |
+8.09% | 9.25B |
- Stock Market
- Equities
- CANF Stock
- News Can-Fite BioPharma Ltd.
- Can Fite BioPharma : Aegis Capital Starts Can-Fite Biopharma at Buy with $5 Price Target